Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

Abstract Background Assessment of measurable residual disease (MRD) is rapidly transforming the therapeutic and prognostic landscape of a wide range of hematological malignancies. Its prognostic value in acute lymphoblastic leukemia (ALL) has been established and MRD measured at the end of induction...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jiří Pavlů, Myriam Labopin, Riitta Niittyvuopio, Gerard Socié, Ibrahim Yakoub-Agha, Depei Wu, Peter Remenyi, Jakob Passweg, Dietrich W. Beelen, Mahmoud Aljurf, Nicolaus Kröger, Hélène Labussière-Wallet, Zinaida Perić, Sebastian Giebel, Arnon Nagler, Mohamad Mohty
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2019-10-01
coleção:	Journal of Hematology & Oncology
Assuntos:	Measurable residual disease Allogeneic hematopoietic cell transplantation Acute lymphoblastic leukemia Allogeneic Myeloablative conditioning Total body irradiation
Acesso em linha:	http://link.springer.com/article/10.1186/s13045-019-0790-x
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!